GLP-1 hormone in arthritis joints

Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a new approach to arthritis treatment. The potential therapeutic implications of this discovery are significant, and further research is needed to fully understand its effects.